Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03528-2Source: DataRank Database

The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature is a research paper published in Journal of Neuro-Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 151 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

151 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 6.54)OA: closedTopics (54)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kyle P. O’Connor ORCID,Ashish H. Shah ORCID,Daniel G. Eichberg ORCID,Evan Luther ORCID,Ricardo J. Komotar ORCID

Live enrichment

PubMed:32385699 OpenAlex:https://openalex.org/W3023953516

National Institutes of Health

Grant: UL1TR002736

National Institutes of Health

Grant: 5UL1TR002736-05

Miami Clinical and Translational Science Institute

FWCI

6.54

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

closedLicense: Springer TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s11060-020-03528-2.pdf

publisherhttps://link.springer.com/article/10.1007/s11060-020-03528-2/fulltext.html

journalhttps://doi.org/10.1007/s11060-020-03528-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32385699

https://dx.doi.org/10.1007/s11060-020-03528-2

Fields of Study

Glioma Diagnosis and TreatmentFerroptosis and cancer prognosisMicrotubule and mitosis dynamics0301 basic medicine0303 health sciences03 medical and health sciencesBrain NeoplasmsCyclin-Dependent Kinase Inhibitor p16GlioblastomaHomozygoteHumansIsocitrate DehydrogenaseNeoplasm GradingPrognosisSequence DeletionSurvival Analysis

MeSH Terms

Brain NeoplasmsGlioblastomaHomozygoteHumansIsocitrate DehydrogenasePrognosisSurvival AnalysisSequence DeletionCyclin-Dependent Kinase Inhibitor p16Neoplasm Grading

Keywords

CDKN2AGliomaOncologyInternal medicineMedicineGlioblastomaIDH1Incidence (geometry)Progression-free survivalMutantOverall survivalCancer researchBiologyCancerGeneGeneticsBrain NeoplasmsHomozygotePrognosisSurvival AnalysisIsocitrate DehydrogenaseHumansNeoplasm GradingCyclin-Dependent Kinase Inhibitor p16Sequence DeletionCyclinDeletionSurvival

Sustainable Development Goals

SDG 3: 3. Good health